Otoimmün Tiroid Hastalıkları ve Tiroid Fonksiyon Testleri

Marelli F., Rurale G., Persani L. From endoderm to progenitors: an update on the early steps of thyroid morphogenesis in the zebrafish. Front Endocrinol. 2021;12. doi:10.3389/fendo.2021.664557

Sulaiman A., Luaibi N., Qassim H. Effects of silver nanoparticles on thyroid gland structure and function in female rats. Asian J Pharm Clin Res. 2018;11(11): 509. doi:10.22159/ajpcr.2018.v11i11.29383

Analytical Science Advances. Analysis of free, unbound thyroid hormones by liquid chromatography‐tandem mass spectrometry: A mini‐review of the medical rationale and analytical methods 2023. (31/03/2024 tarihinde https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/ansa.202200067 adresinden ulaşılmıştır).

Califaretti E., Dall'armellina S., Rovera G. The role of PET/CT in thyroid autoimmune diseases. Q J Nucl Med Mol Imaging. 2022;66(3): 218–228. doi.org/10.23736/S1824-4785.22.03464-1

Liu Y., Liu X., Wu N. Int G Jen Med. 2023;16: 2355–2363. doi.org/10.2147/IJGM.S410640

Yoo W. and Chung H. Endocrinol Metab. 2016;31(3): 379. doi.org/10.3803/enm.2016.31.3.379

Ferrari S., Ragusa F., Elia G. Front Pharmacol. 2021;12. doi.org/10.3389/fphar.2021.750380

Spencer C-A, Feingold K-R., Anawalt B. Assay of Thyroid Hormones and Related Substances. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.2017 Feb 20. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279113/

Kapoor N., Kurian M. Interpretation of thyroid function tests. Current Medical Issues. 2018;16(2): 34. doi.org/10.4103/cmi.cmi_17_18

Gulnara Dashdamirova. R-A., Rahimova Samira Baghirova., Ulviya Azizova. Pathogenic Mechanisms of Autoimmune Thyroid Disease. Int J Med Sci. 2022;6(2): 26-33. doi.org/10.51505/ijmshr.2022.6203

Kumata S., Hashimoto Y., Okada H. Pulmonary hypertension associated with hyperthyroidism: a case report. Cureus. 2022. doi.org/10.7759/cureus.30567

Salah R., Kacem F., Soomauro S. Autoimmune thyroiditis associated with autoimmune diseases. Electron J Gen Med. 2022;19(6): 409. doi.org/10.29333/ejgm/12399

Albadrani A. Altobje M-A. Conducting Hormonal, Biochemical and Serological Tests in Autoimmune Thyroid Patients. South Asian J. Res. Microbiol. 2022;12(4): 6–14. doi.org/10.9734/sajrm/2022/v12i430281

Vurgun E., Baltan E., Serin H. Tiroid Hormonları Referans Aralıkları Reference Intervals of Thyroid Hormones Tiroid Hormonları Referans Aralıklarının Belirlenmesi: Merkezi Laboratuvar Verilerinden Determination of Reference Intervals of Thyroid Hormones: from a Central Laboratory Data. Turkish Journal of Biochemistry. 2022;20(1): 29–36.

Lewandowski K., Gąsior-Perczak D., Kowalska A. Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease. Thyroid Research. 2012;5(1). doi.org/10.1186/1756-6614-5-20

Fu J., Wu A., Wang X. Concurrent graves' disease and tsh secreting pituitary adenoma presenting suppressed thyrotropin levels: a case report and review of the literature. Front. Endocrinol. 2020;11. doi.org/10.3389/fendo.2020.00523

Oueslati I., Salhi S., Yazidi A case of hashimoto's thyroiditis following graves' disease. Clin. Case Rep. 2022;10(10). doi.org/10.1002/ccr3.6466

Marcocci C., Leo M., Altea M. Oxidative stress in graves disease. Eur. Thyroid J. 2012;1(2): 80-87. doi.org/10.1159/000337976

Nguyen J. and Joseph D. Graves’ disease in an adolescent presenting with increased intracranial pressure and bilateral papilledema. JCEM Case Rep. 2022. doi.org/10.1530/edm-22-0240

Gursu T., Cevik H., Desteli G-A. Diagnostic value of shear wave velocity in polycystic ovarian syndrome. J Ultrason. 2021. doi:10.15557/JoU.2021.0047

Taylor P., Zhang L., Lee R. New insights into the pathogenesis and nonsurgical management of graves orbitopathy. Nat Rev Endocrinol. 2019;16(2): 104-116. doi.org/10.1038/s41574-019-0305-4

Kotwal N., Singh Y., Menon A. Thymic hyperplasia in graves′ disease. Indian J Endocrinol Metab. 2013;17(3): 521. doi.org/10.4103/2230-8210.111676

Kumata S., Hashimoto Y., Okada H. Pulmonary hypertension associated with hyperthyroidism: a case report. Cureus. 2022. doi.org/10.7759/cureus.30567

Elenius H., Cesa M., Suárez C. Thyrotoxic periodic paralysis causing back pain and leg weakness: an unusual presentation of hyperthyroidism. Case Rep Endocrinol. 2021;1-4. doi.org/10.1155/2021/6622658

TEMD. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu,2023. [Online] https://file.temd.org.tr/Uploads/publications/guides/documents/202305120904-2023tbl_kilavuz.pdf [Accessed: 20th March 2024]

Macovei M., Azis Ű., Gheorghe A., A systematic review of euthyroid graves' disease (review). Exp Ther Med. 2021;22(5). doi.org/10.3892/etm.2021.10781

Shahbaz A., Aziz K., Umair M. Graves' disease presenting as painful goiter: a case report and review of the literature. Cureus. 2018. doi.org/10.7759/cureus.2765

Wang S., Wang C., Tien K. Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset graves' disease treated with antithyroid drugs. The Kaohsiung J Med Sci. 2019;36(4): 281-286. doi.org/10.1002/kjm2.12167

Gallo D., Piantanida E., Gallazzi M. Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher. Front Endocrinol. 2020;11: 406. doi.org/10.3389/fendo.2020.00406

Hiruma M., Watanabe N., Mitsumatsu T. Clinical features of moyamoya disease with graves’ disease: a retrospective study of 394,422 patients with thyroid disease. Endocr J. 2023;70(2): 141-148. doi.org/10.1507/endocrj.ej22-0319

Azeez T., Egbu A. Clinical profiles of thyroid dermopathy: a dermato-endocrinology minireview. Endocrinol Metab Int J. 2020;8(6): 125-127. doi.org/10.15406/emij.2020.08.00294

Kaewdech A., Aiempanakit K., Sangmala S. Elephantiasic pretibial myxedema: a rare manifestation in graves’ disease. J Health Sci Med Res. 2019. doi.org/10.31584/jhsmr.201942

Piltcher-da-Silva R., Morillos M., Bertão S. Severe cholestatic syndrome secondary to graves disease. Clin.Biomed. Res. 2019;39(1): 101-103. doi.org/10.4322/2357-9730.87476

Lee C., Chen S., Yang Y. Association between graves' disease and risk of incident systemic lupus erythematosus: a nationwide population‐based cohort study. Int J Rheu Dis. 2020;24(2): 240-245. doi.org/10.1111/1756-185x.14027

TEMD. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu,2020. [Online] https://file.temd.org.tr/Uploads/publications/guides/documents/20200929134733-2020tbl_kilavuzf527c34496.pdf?a=1 [Accessed: 20th March 2024]

Kızılkan M., Kanbur N., Akgül S. An adolescent boy with comorbid anorexia nervosa and hashimoto thyroiditis. J Clin Res Ped Endocrinol. 2016;8(1): 92-95. doi.org/10.4274/jcrpe.2297

Dong L., Sun X., Cheng X. Hashimoto's thyroiditis and papillary carcinoma in an adolescent girl: a case report. Mol Clin Oncol. 2016;5(1): 129-131. doi.org/10.3892/mco.2016.895

Klubo-Gwiezdzinska J., Wartofsky L. Hashimoto thyroiditis: an evidence-based guide: etiology, diagnosis and treatment. Pol Arch Int Med. 2022. doi.org/10.20452/pamw.16222

Casler K. Laboratory Policy and Regulations. Gawlik K. (Ed.) Laboratory Screening and Diagnostic Evaluation: An Evidence Based Approach içinde. New York: Springer Publishing Company; 2022. p. 25-30

Koulouri O., Gurnell M. How to interpret thyroid function tests. Clin Med. 2013;13(3): 282–286. doi.org/10.7861/clinmedicine.13-3-282

Thienpont L., Uytfanghe K., Grande L. Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval. Clin Chem. 2017;63(7): 1248-1260. doi.org/10.1373/clinchem.2016.269456

Peters C., Trotsenburg A., Schoenmakers N. Diagnosis of endocrine disease: congenital hypothyroidism: update and perspectives. Acta Endocrinol. 2018;179(6): 297-317. doi.org/10.1530/eje-18-0383

Abdi H., Davoodi S., Gharibzadeh S. Association between thyroid function and body mass index: a 10-year follow-up. Ann Nutr Metab. 2017;70(4): 338-345. doi.org/10.1159/000477497

Hoermann R., Eckl W., Hoermann C. Complex relationship between free thyroxine and tsh in the regulation of thyroid function. Acta Endocrinol. 2010;162(6): 1123-1129. doi.org/10.1530/eje-10-0106

Shemesh R., Simon G., Zloto O. The role of thyroid antibodies in thyroid eye disease. Int Ophthalmol Clin. 2023;63(3): 225-231. doi.org/10.1097/iio.0000000000000451

Wanjia X., Jiajun Z. TSH in the Upper Limits Of The Normal Range Is Associated With An Adverse Lipid Profile in Euthyroid Non-Diabetics With Newly Diagnosed Asymptomatic Coronary Heart Disease. Heart. 2012;98: 161-162. doi.org/10.1136/heartjnl-2012-302920j.9

Meng F., Jonklaas J., Leow M. Interconversion of plasma free thyroxine values from assay platforms with different reference intervals using linear transformation methods. Biology. 2021;10(1): 45. doi.org/10.3390/biology10010045

Padoan A., Clerico A., Zaninotto M. Percentile transformation and recalibration functions allow harmonization of thyroid-stimulating hormone (tsh) immunoassay results. Clin. Chem Lab Med. 2020;58(10): 1663-1672. doi.org/10.1515/cclm-2019-1167

Grande L., Uytfanghe K., Reynders D. Standardization of free thyroxine measurements allows the adoption of a more uniform reference interval. Clin Chem. 2017;63(10): 1642-1652. doi.org/10.1373/clinchem.2017.274407

Marras, V., Casini, M., Pilia, S. Thyroid function in obese children and adolescents. Horm Res Paediatr. 2010;73(3): 193-197. doi.org/10.1159/000284361

Wolters B., Lass N., Reinehr T. Tsh and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children. Acta Endocrinol. 2013;168(3): 323-329. doi.org/10.1530/eje-12-0981

Torun E., Özgen İ., Gökçe S. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2014;6(1): 34-39. doi.org/10.4274/jcrpe.1155

Chu C., Lam H., Lee J. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels. J Thyroid Res. 2011;1-5. doi.org/10.4061/2011/194721

Singh S., Lamsal M., Baral N. Correlation of iodine content of mother’s milk and urine with their child’s tsh level. Asian J Med Sci. 2015;7(1): 40-48. doi.org/10.3126/ajms.v7i1.12577

Clerico A., Trenti T., Aloe R. A multicenter study for the evaluation of the reference interval for tsh in Italy. Clin Chem Lab Med. 2018;57(2): 259-267. doi.org/10.1515/cclm-2018-0541

Witte T., Völzke H., Lerch M. Association between serum thyroid-stimulating hormone levels and visceral adipose tissue: a population-based study in northeast germany. Eur Thyroid J. 2016;6(1): 12-19. doi.org/10.1159/000450977

Miao Wang, Jing Li, Youyuan Huang. Analytical validation of the LiCA® high-sensitivity human thyroid stimulating hormone assay. Clin Biochem. 2022;101: 42–49. doi:10.1016/j.clinbiochem.2021.11.018

Bikle D-D. The Free Hormone Hypothesis: When, Why, and How to Measure the Free Hormone Levels to Assess Vitamin D, Thyroid, Sex Hormone, and Cortisol Status. JBMR Plus. 2020;11(2); 5. doi.org/10.1002/jbm4.10418

Carvalho G-A-D., Perez C-L-S., Ward L-S. The clinical use of thyroid function tests. Arq Bras Endocrinol Metab. 2013;57(3); 193–204. doi.org/10.1590/s0004-27302013000300005

Marelli F., Rurale G., Persani L. From endoderm to progenitors: an update on the early steps of thyroid morphogenesis in the zebrafish. Front Endocrinol. 2021;12. doi:10.3389/fendo.2021.664557

Sulaiman A., Luaibi N., Qassim H. Effects of silver nanoparticles on thyroid gland structure and function in female rats. Asian J Pharm Clin Res. 2018;11(11): 509. doi:10.22159/ajpcr.2018.v11i11.29383

Analytical Science Advances. Analysis of free, unbound thyroid hormones by liquid chromatography‐tandem mass spectrometry: A mini‐review of the medical rationale and analytical methods 2023. (31/03/2024 tarihinde https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/ansa.202200067 adresinden ulaşılmıştır).

Califaretti E., Dall'armellina S., Rovera G. The role of PET/CT in thyroid autoimmune diseases. Q J Nucl Med Mol Imaging. 2022;66(3): 218–228. doi.org/10.23736/S1824-4785.22.03464-1

Liu Y., Liu X., Wu N. Int G Jen Med. 2023;16: 2355–2363. doi.org/10.2147/IJGM.S410640

Yoo W. and Chung H. Endocrinol Metab. 2016;31(3): 379. doi.org/10.3803/enm.2016.31.3.379

Ferrari S., Ragusa F., Elia G. Front Pharmacol. 2021;12. doi.org/10.3389/fphar.2021.750380

Spencer C-A, Feingold K-R., Anawalt B. Assay of Thyroid Hormones and Related Substances. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.2017 Feb 20. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279113/

Kapoor N., Kurian M. Interpretation of thyroid function tests. Current Medical Issues. 2018;16(2): 34. doi.org/10.4103/cmi.cmi_17_18

Gulnara Dashdamirova. R-A., Rahimova Samira Baghirova., Ulviya Azizova. Pathogenic Mechanisms of Autoimmune Thyroid Disease. Int J Med Sci. 2022;6(2): 26-33. doi.org/10.51505/ijmshr.2022.6203

Kumata S., Hashimoto Y., Okada H. Pulmonary hypertension associated with hyperthyroidism: a case report. Cureus. 2022. doi.org/10.7759/cureus.30567

Salah R., Kacem F., Soomauro S. Autoimmune thyroiditis associated with autoimmune diseases. Electron J Gen Med. 2022;19(6): 409. doi.org/10.29333/ejgm/12399

Albadrani A. Altobje M-A. Conducting Hormonal, Biochemical and Serological Tests in Autoimmune Thyroid Patients. South Asian J. Res. Microbiol. 2022;12(4): 6–14. doi.org/10.9734/sajrm/2022/v12i430281

Vurgun E., Baltan E., Serin H. Tiroid Hormonları Referans Aralıkları Reference Intervals of Thyroid Hormones Tiroid Hormonları Referans Aralıklarının Belirlenmesi: Merkezi Laboratuvar Verilerinden Determination of Reference Intervals of Thyroid Hormones: from a Central Laboratory Data. Turkish Journal of Biochemistry. 2022;20(1): 29–36.

Lewandowski K., Gąsior-Perczak D., Kowalska A. Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease. Thyroid Research. 2012;5(1). doi.org/10.1186/1756-6614-5-20

Fu J., Wu A., Wang X. Concurrent graves' disease and tsh secreting pituitary adenoma presenting suppressed thyrotropin levels: a case report and review of the literature. Front. Endocrinol. 2020;11. doi.org/10.3389/fendo.2020.00523

Oueslati I., Salhi S., Yazidi A case of hashimoto's thyroiditis following graves' disease. Clin. Case Rep. 2022;10(10). doi.org/10.1002/ccr3.6466

Marcocci C., Leo M., Altea M. Oxidative stress in graves disease. Eur. Thyroid J. 2012;1(2): 80-87. doi.org/10.1159/000337976

Nguyen J. and Joseph D. Graves’ disease in an adolescent presenting with increased intracranial pressure and bilateral papilledema. JCEM Case Rep. 2022. doi.org/10.1530/edm-22-0240

Gursu T., Cevik H., Desteli G-A. Diagnostic value of shear wave velocity in polycystic ovarian syndrome. J Ultrason. 2021. doi:10.15557/JoU.2021.0047

Taylor P., Zhang L., Lee R. New insights into the pathogenesis and nonsurgical management of graves orbitopathy. Nat Rev Endocrinol. 2019;16(2): 104-116. doi.org/10.1038/s41574-019-0305-4

Kotwal N., Singh Y., Menon A. Thymic hyperplasia in graves′ disease. Indian J Endocrinol Metab. 2013;17(3): 521. doi.org/10.4103/2230-8210.111676

Kumata S., Hashimoto Y., Okada H. Pulmonary hypertension associated with hyperthyroidism: a case report. Cureus. 2022. doi.org/10.7759/cureus.30567

Elenius H., Cesa M., Suárez C. Thyrotoxic periodic paralysis causing back pain and leg weakness: an unusual presentation of hyperthyroidism. Case Rep Endocrinol. 2021;1-4. doi.org/10.1155/2021/6622658

TEMD. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu,2023. [Online] https://file.temd.org.tr/Uploads/publications/guides/documents/202305120904-2023tbl_kilavuz.pdf [Accessed: 20th March 2024]

Macovei M., Azis Ű., Gheorghe A., A systematic review of euthyroid graves' disease (review). Exp Ther Med. 2021;22(5). doi.org/10.3892/etm.2021.10781

Shahbaz A., Aziz K., Umair M. Graves' disease presenting as painful goiter: a case report and review of the literature. Cureus. 2018. doi.org/10.7759/cureus.2765

Wang S., Wang C., Tien K. Thyroid‐stimulating hormone receptor antibodies during follow‐up as remission markers in childhood‐onset graves' disease treated with antithyroid drugs. The Kaohsiung J Med Sci. 2019;36(4): 281-286. doi.org/10.1002/kjm2.12167

Gallo D., Piantanida E., Gallazzi M. Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher. Front Endocrinol. 2020;11: 406. doi.org/10.3389/fendo.2020.00406

Hiruma M., Watanabe N., Mitsumatsu T. Clinical features of moyamoya disease with graves’ disease: a retrospective study of 394,422 patients with thyroid disease. Endocr J. 2023;70(2): 141-148. doi.org/10.1507/endocrj.ej22-0319

Azeez T., Egbu A. Clinical profiles of thyroid dermopathy: a dermato-endocrinology minireview. Endocrinol Metab Int J. 2020;8(6): 125-127. doi.org/10.15406/emij.2020.08.00294

Kaewdech A., Aiempanakit K., Sangmala S. Elephantiasic pretibial myxedema: a rare manifestation in graves’ disease. J Health Sci Med Res. 2019. doi.org/10.31584/jhsmr.201942

Piltcher-da-Silva R., Morillos M., Bertão S. Severe cholestatic syndrome secondary to graves disease. Clin.Biomed. Res. 2019;39(1): 101-103. doi.org/10.4322/2357-9730.87476

Lee C., Chen S., Yang Y. Association between graves' disease and risk of incident systemic lupus erythematosus: a nationwide population‐based cohort study. Int J Rheu Dis. 2020;24(2): 240-245. doi.org/10.1111/1756-185x.14027

TEMD. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu,2020. [Online] https://file.temd.org.tr/Uploads/publications/guides/documents/20200929134733-2020tbl_kilavuzf527c34496.pdf?a=1 [Accessed: 20th March 2024]

Kızılkan M., Kanbur N., Akgül S. An adolescent boy with comorbid anorexia nervosa and hashimoto thyroiditis. J Clin Res Ped Endocrinol. 2016;8(1): 92-95. doi.org/10.4274/jcrpe.2297

Dong L., Sun X., Cheng X. Hashimoto's thyroiditis and papillary carcinoma in an adolescent girl: a case report. Mol Clin Oncol. 2016;5(1): 129-131. doi.org/10.3892/mco.2016.895

Klubo-Gwiezdzinska J., Wartofsky L. Hashimoto thyroiditis: an evidence-based guide: etiology, diagnosis and treatment. Pol Arch Int Med. 2022. doi.org/10.20452/pamw.16222

Casler K. Laboratory Policy and Regulations. Gawlik K. (Ed.) Laboratory Screening and Diagnostic Evaluation: An Evidence Based Approach içinde. New York: Springer Publishing Company; 2022. p. 25-30

Koulouri O., Gurnell M. How to interpret thyroid function tests. Clin Med. 2013;13(3): 282–286. doi.org/10.7861/clinmedicine.13-3-282

Thienpont L., Uytfanghe K., Grande L. Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval. Clin Chem. 2017;63(7): 1248-1260. doi.org/10.1373/clinchem.2016.269456

Peters C., Trotsenburg A., Schoenmakers N. Diagnosis of endocrine disease: congenital hypothyroidism: update and perspectives. Acta Endocrinol. 2018;179(6): 297-317. doi.org/10.1530/eje-18-0383

Abdi H., Davoodi S., Gharibzadeh S. Association between thyroid function and body mass index: a 10-year follow-up. Ann Nutr Metab. 2017;70(4): 338-345. doi.org/10.1159/000477497

Hoermann R., Eckl W., Hoermann C. Complex relationship between free thyroxine and tsh in the regulation of thyroid function. Acta Endocrinol. 2010;162(6): 1123-1129. doi.org/10.1530/eje-10-0106

Shemesh R., Simon G., Zloto O. The role of thyroid antibodies in thyroid eye disease. Int Ophthalmol Clin. 2023;63(3): 225-231. doi.org/10.1097/iio.0000000000000451

Wanjia X., Jiajun Z. TSH in the Upper Limits Of The Normal Range Is Associated With An Adverse Lipid Profile in Euthyroid Non-Diabetics With Newly Diagnosed Asymptomatic Coronary Heart Disease. Heart. 2012;98: 161-162. doi.org/10.1136/heartjnl-2012-302920j.9

Meng F., Jonklaas J., Leow M. Interconversion of plasma free thyroxine values from assay platforms with different reference intervals using linear transformation methods. Biology. 2021;10(1): 45. doi.org/10.3390/biology10010045

Padoan A., Clerico A., Zaninotto M. Percentile transformation and recalibration functions allow harmonization of thyroid-stimulating hormone (tsh) immunoassay results. Clin. Chem Lab Med. 2020;58(10): 1663-1672. doi.org/10.1515/cclm-2019-1167

Grande L., Uytfanghe K., Reynders D. Standardization of free thyroxine measurements allows the adoption of a more uniform reference interval. Clin Chem. 2017;63(10): 1642-1652. doi.org/10.1373/clinchem.2017.274407

Marras, V., Casini, M., Pilia, S. Thyroid function in obese children and adolescents. Horm Res Paediatr. 2010;73(3): 193-197. doi.org/10.1159/000284361

Wolters B., Lass N., Reinehr T. Tsh and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children. Acta Endocrinol. 2013;168(3): 323-329. doi.org/10.1530/eje-12-0981

Torun E., Özgen İ., Gökçe S. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol. 2014;6(1): 34-39. doi.org/10.4274/jcrpe.1155

Chu C., Lam H., Lee J. Hyperthyroidism-associated insulin resistance is not mediated by adiponectin levels. J Thyroid Res. 2011;1-5. doi.org/10.4061/2011/194721

Singh S., Lamsal M., Baral N. Correlation of iodine content of mother’s milk and urine with their child’s tsh level. Asian J Med Sci. 2015;7(1): 40-48. doi.org/10.3126/ajms.v7i1.12577

Clerico A., Trenti T., Aloe R. A multicenter study for the evaluation of the reference interval for tsh in Italy. Clin Chem Lab Med. 2018;57(2): 259-267. doi.org/10.1515/cclm-2018-0541

Witte T., Völzke H., Lerch M. Association between serum thyroid-stimulating hormone levels and visceral adipose tissue: a population-based study in northeast germany. Eur Thyroid J. 2016;6(1): 12-19. doi.org/10.1159/000450977

Miao Wang, Jing Li, Youyuan Huang. Analytical validation of the LiCA® high-sensitivity human thyroid stimulating hormone assay. Clin Biochem. 2022;101: 42–49. doi:10.1016/j.clinbiochem.2021.11.018

Bikle D-D. The Free Hormone Hypothesis: When, Why, and How to Measure the Free Hormone Levels to Assess Vitamin D, Thyroid, Sex Hormone, and Cortisol Status. JBMR Plus. 2020;11(2); 5. doi.org/10.1002/jbm4.10418

Carvalho G-A-D., Perez C-L-S., Ward L-S. The clinical use of thyroid function tests. Arq Bras Endocrinol Metab. 2013;57(3); 193–204. doi.org/10.1590/s0004-27302013000300005